Unable to display view head.php file not found.

Activity Overview

Current treatment algorithms reflect the importance of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the management of type 2 diabetes. However, clinicians often struggle with how to apply these recommendations in the context of recent clinical evidence, including efficacy, safety, nonglycemic effects, and patient-reported outcomes. In this program, participants will review 2 case studies presented through physician-patient interviews. The faculty panel will discuss each case in the context of available evidence and provide clinical recommendations based on their expertise.

If you wish to claim CME/ANCC credit, please so do here
Unable to display view foot.php file not found.